UBS AM’s Cognyte Software CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35.4K Buy
+4,077
New +$35.7K ﹤0.01% 3500
2022
Q4
– Sell
-87,771
Closed -$355K – 2603
2022
Q3
$355K Hold
87,771
– – ﹤0.01% 2459
2022
Q2
$373K Buy
87,771
+10,858
+14% +$76.1K ﹤0.01% 2395
2022
Q1
$870K Hold
76,913
– – ﹤0.01% 2213
2021
Q4
$1.21M Hold
76,913
– – ﹤0.01% 2111
2021
Q3
$1.58M Buy
76,913
+22,098
+40% +$565K ﹤0.01% 1939
2021
Q2
$1.34M Buy
+54,815
New +$1.36M ﹤0.01% 2039

Other funds holding CGNT

UBS AM's CGNT Position: Q3 2026 in Review

UBS AM opened a new position in Cognyte Software (CGNT) in Q3 2026: 4,077 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #3500 among its holdings. This is a return to the name: UBS AM previously reported a position in CGNT as recently as Q3 2022.

UBS AM first reported a position in CGNT in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.58M in Q3 2021. 128 funds tracked by Wall St. Rank hold CGNT as of Q3 2026.

  • UBS AM held 4,077 shares of Cognyte Software worth $35.4K as of Q3 2026.
  • Cognyte Software was a new UBS AM position in Q3 2026.
  • Cognyte Software made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3500 holding.
  • UBS AM first reported a position in Cognyte Software in Q2 2021 and has held it in 7 quarters since.
  • UBS AM's Cognyte Software position peaked at $1.58M in Q3 2021.
  • 128 funds tracked by Wall St. Rank held Cognyte Software as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.